0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy Medicinal Products (GTMP) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-29P13978
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Therapy Medicinal Products GTMP Market Research Report 2023
BUY CHAPTERS

Global Gene Therapy Medicinal Products (GTMP) Market Research Report 2025

Code: QYRE-Auto-29P13978
Report
July 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Therapy Medicinal Products (GTMP) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gene Therapy Medicinal Products (GTMP) Market

Gene Therapy Medicinal Products (GTMP) Market

The global market for Gene Therapy Medicinal Products (GTMP) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy Medicinal Products (GTMP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy Medicinal Products (GTMP).
The Gene Therapy Medicinal Products (GTMP) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy Medicinal Products (GTMP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy Medicinal Products (GTMP) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Therapy Medicinal Products (GTMP) Market Report

Report Metric Details
Report Name Gene Therapy Medicinal Products (GTMP) Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Therapy Medicinal Products (GTMP) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapy Medicinal Products (GTMP) Market report?

Ans: The main players in the Gene Therapy Medicinal Products (GTMP) Market are Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene

What are the Application segmentation covered in the Gene Therapy Medicinal Products (GTMP) Market report?

Ans: The Applications covered in the Gene Therapy Medicinal Products (GTMP) Market report are Cancer, Monogenic, Infectious Disease, Cardiovascular Disease, Other

What are the Type segmentation covered in the Gene Therapy Medicinal Products (GTMP) Market report?

Ans: The Types covered in the Gene Therapy Medicinal Products (GTMP) Market report are Oral, Injection

Recommended Reports

Gene Therapy Markets

Genetic Testing & Diagnostics

Advanced Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Gene Therapy Medicinal Products (GTMP) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious Disease
1.3.5 Cardiovascular Disease
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Medicinal Products (GTMP) Market Perspective (2020-2031)
2.2 Global Gene Therapy Medicinal Products (GTMP) Growth Trends by Region
2.2.1 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Therapy Medicinal Products (GTMP) Historic Market Size by Region (2020-2025)
2.2.3 Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Region (2026-2031)
2.3 Gene Therapy Medicinal Products (GTMP) Market Dynamics
2.3.1 Gene Therapy Medicinal Products (GTMP) Industry Trends
2.3.2 Gene Therapy Medicinal Products (GTMP) Market Drivers
2.3.3 Gene Therapy Medicinal Products (GTMP) Market Challenges
2.3.4 Gene Therapy Medicinal Products (GTMP) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Medicinal Products (GTMP) Players by Revenue
3.1.1 Global Top Gene Therapy Medicinal Products (GTMP) Players by Revenue (2020-2025)
3.1.2 Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Players (2020-2025)
3.2 Global Gene Therapy Medicinal Products (GTMP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Therapy Medicinal Products (GTMP) Revenue
3.4 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio
3.4.1 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Medicinal Products (GTMP) Revenue in 2024
3.5 Global Key Players of Gene Therapy Medicinal Products (GTMP) Head office and Area Served
3.6 Global Key Players of Gene Therapy Medicinal Products (GTMP), Product and Application
3.7 Global Key Players of Gene Therapy Medicinal Products (GTMP), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Type
4.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Type (2020-2025)
4.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2026-2031)
5 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Application
5.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Application (2020-2025)
5.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Therapy Medicinal Products (GTMP) Market Size (2020-2031)
6.2 North America Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2020-2025)
6.4 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size (2020-2031)
7.2 Europe Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2020-2025)
7.4 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size (2020-2031)
8.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size (2020-2031)
9.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2020-2025)
9.4 Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size (2020-2031)
10.2 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.1.4 Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
11.1.5 Bluebird Bio Recent Development
11.2 Sangamo
11.2.1 Sangamo Company Details
11.2.2 Sangamo Business Overview
11.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Introduction
11.2.4 Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
11.2.5 Sangamo Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.3.4 Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
11.3.5 Spark Therapeutics Recent Development
11.4 Dimension Therapeutics
11.4.1 Dimension Therapeutics Company Details
11.4.2 Dimension Therapeutics Business Overview
11.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.4.4 Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
11.4.5 Dimension Therapeutics Recent Development
11.5 Avalanche Bio
11.5.1 Avalanche Bio Company Details
11.5.2 Avalanche Bio Business Overview
11.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.5.4 Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
11.5.5 Avalanche Bio Recent Development
11.6 Celladon
11.6.1 Celladon Company Details
11.6.2 Celladon Business Overview
11.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Introduction
11.6.4 Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
11.6.5 Celladon Recent Development
11.7 Vical Inc.
11.7.1 Vical Inc. Company Details
11.7.2 Vical Inc. Business Overview
11.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Introduction
11.7.4 Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
11.7.5 Vical Inc. Recent Development
11.8 Advantagene
11.8.1 Advantagene Company Details
11.8.2 Advantagene Business Overview
11.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Introduction
11.8.4 Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
11.8.5 Advantagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral
 Table 3. Key Players of Injection
 Table 4. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Gene Therapy Medicinal Products (GTMP) Market Share by Region (2020-2025)
 Table 8. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Gene Therapy Medicinal Products (GTMP) Market Share by Region (2026-2031)
 Table 10. Gene Therapy Medicinal Products (GTMP) Market Trends
 Table 11. Gene Therapy Medicinal Products (GTMP) Market Drivers
 Table 12. Gene Therapy Medicinal Products (GTMP) Market Challenges
 Table 13. Gene Therapy Medicinal Products (GTMP) Market Restraints
 Table 14. Global Gene Therapy Medicinal Products (GTMP) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Gene Therapy Medicinal Products (GTMP) Market Share by Players (2020-2025)
 Table 16. Global Top Gene Therapy Medicinal Products (GTMP) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2024)
 Table 17. Ranking of Global Top Gene Therapy Medicinal Products (GTMP) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Gene Therapy Medicinal Products (GTMP) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Gene Therapy Medicinal Products (GTMP), Headquarters and Area Served
 Table 20. Global Key Players of Gene Therapy Medicinal Products (GTMP), Product and Application
 Table 21. Global Key Players of Gene Therapy Medicinal Products (GTMP), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Gene Therapy Medicinal Products (GTMP) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2020-2025)
 Table 25. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2026-2031)
 Table 27. Global Gene Therapy Medicinal Products (GTMP) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2020-2025)
 Table 29. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Application (2026-2031)
 Table 31. North America Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Bluebird Bio Company Details
 Table 47. Bluebird Bio Business Overview
 Table 48. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Product
 Table 49. Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025) & (US$ Million)
 Table 50. Bluebird Bio Recent Development
 Table 51. Sangamo Company Details
 Table 52. Sangamo Business Overview
 Table 53. Sangamo Gene Therapy Medicinal Products (GTMP) Product
 Table 54. Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025) & (US$ Million)
 Table 55. Sangamo Recent Development
 Table 56. Spark Therapeutics Company Details
 Table 57. Spark Therapeutics Business Overview
 Table 58. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Product
 Table 59. Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025) & (US$ Million)
 Table 60. Spark Therapeutics Recent Development
 Table 61. Dimension Therapeutics Company Details
 Table 62. Dimension Therapeutics Business Overview
 Table 63. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Product
 Table 64. Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025) & (US$ Million)
 Table 65. Dimension Therapeutics Recent Development
 Table 66. Avalanche Bio Company Details
 Table 67. Avalanche Bio Business Overview
 Table 68. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Product
 Table 69. Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025) & (US$ Million)
 Table 70. Avalanche Bio Recent Development
 Table 71. Celladon Company Details
 Table 72. Celladon Business Overview
 Table 73. Celladon Gene Therapy Medicinal Products (GTMP) Product
 Table 74. Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025) & (US$ Million)
 Table 75. Celladon Recent Development
 Table 76. Vical Inc. Company Details
 Table 77. Vical Inc. Business Overview
 Table 78. Vical Inc. Gene Therapy Medicinal Products (GTMP) Product
 Table 79. Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025) & (US$ Million)
 Table 80. Vical Inc. Recent Development
 Table 81. Advantagene Company Details
 Table 82. Advantagene Business Overview
 Table 83. Advantagene Gene Therapy Medicinal Products (GTMP) Product
 Table 84. Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2020-2025) & (US$ Million)
 Table 85. Advantagene Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Gene Therapy Medicinal Products (GTMP) Picture
 Figure 2. Global Gene Therapy Medicinal Products (GTMP) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gene Therapy Medicinal Products (GTMP) Market Share by Type: 2024 VS 2031
 Figure 4. Oral Features
 Figure 5. Injection Features
 Figure 6. Global Gene Therapy Medicinal Products (GTMP) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gene Therapy Medicinal Products (GTMP) Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Case Studies
 Figure 9. Monogenic Case Studies
 Figure 10. Infectious Disease Case Studies
 Figure 11. Cardiovascular Disease Case Studies
 Figure 12. Other Case Studies
 Figure 13. Gene Therapy Medicinal Products (GTMP) Report Years Considered
 Figure 14. Global Gene Therapy Medicinal Products (GTMP) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Gene Therapy Medicinal Products (GTMP) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Gene Therapy Medicinal Products (GTMP) Market Share by Region: 2024 VS 2031
 Figure 17. Global Gene Therapy Medicinal Products (GTMP) Market Share by Players in 2024
 Figure 18. Global Top Gene Therapy Medicinal Products (GTMP) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Gene Therapy Medicinal Products (GTMP) Revenue in 2024
 Figure 20. North America Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2020-2031)
 Figure 22. United States Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Gene Therapy Medicinal Products (GTMP) Market Share by Country (2020-2031)
 Figure 26. Germany Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Share by Region (2020-2031)
 Figure 34. China Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2020-2031)
 Figure 42. Mexico Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Share by Country (2020-2031)
 Figure 46. Turkey Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Bluebird Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
 Figure 50. Sangamo Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
 Figure 51. Spark Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
 Figure 52. Dimension Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
 Figure 53. Avalanche Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
 Figure 54. Celladon Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
 Figure 55. Vical Inc. Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
 Figure 56. Advantagene Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS